Oct 09, 2015 at 15:08 | Source: PTI
"The company has received the final approval from the US Food and Drug Administration (USFDA) to manufacture and market Aripiprazole tablets... and the product is ready for launch," Aurobindo Pharma said in a statement on Friday.
Oct 09, 2015 at 13:10 | Source: Moneycontrol.com
"The company has received final approval from USFDA to manufacture and market Aripiprazole tablets, 2mg, 5mg, 10mg, 15mg, 20mg and 30mg," the pharma company said, adding the product is ready for launch.
Oct 08, 2015 at 16:35 | Source: PTI
The recommendation comes against the backdrop of recent demand of the Association of Power Producers (APP) that the ministry's order to restrain ash content in imported coal up to 12 per cent has forced power plants in the coastal region to use only Indonesian coal.
Oct 08, 2015 at 15:03 | Source: Moneycontrol.com
Capri Global Capital's wholly owned subsidiary Capri Global Housing Finance announced the receipt of certificate if registration from National Housing Bank (NHB) to launch its housing finance business.
Oct 08, 2015 at 11:53 | Source: Moneycontrol.com
Shareholders also approved issuing foreign currency convertible bonds (FCCBs), global depository receipts (GDRs), American depository receipts (ADRs), warrants convertible into shares.
Oct 07, 2015 at 15:14 | Source: PTI
The company is a joint venture between state-owned firms, the country's major power producer NTPC and steel major SAIL.
Oct 07, 2015 at 13:13 | Source: PTI
In a BSE filing, Jubilant Life Sciences said it "received Abbreviated New Drug Application (ANDA) final approval from the US Food and Drug Administration (USFDA) for Indomethacin ER Capsule 75mg, which is a non-steriodal anti-inflammatory drug used for treatment of pain".
Oct 07, 2015 at 11:34 | Source: PTI
Last week, eight public sector banks, including SBI, Punjab National Bank and Bank of Baroda, had allotted equity shares on preferential basis to the government against capital infusion of Rs 13,955 crore.
Oct 07, 2015 at 09:58 | Source: Moneycontrol.com
Olmesartan Medoxomil is used for the treatment of high blood pressure. The drug was developed by Sankyo (now known as Daiichi Sankyo).
Oct 06, 2015 at 22:31 | Source: PTI
The Pune-headquartered company had applied to the regulator National Housing Bank for a licence to start the home finance business through a wholly-owned subsidiary last year, it said in a statement.